BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38070160)

  • 1. Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event.
    Sztejkowski C; Sibilia J; Danion F; Mertz P; Elodie F; Kassegne L; Boyer P; Puéchal X; Gottenberg JE; Scherlinger M
    Rheumatology (Oxford); 2024 May; 63(6):e185-e187. PubMed ID: 38070160
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate use in rheumatoid arthritis.
    O'Dell JR
    Rheum Dis Clin North Am; 1997 Nov; 23(4):779-96. PubMed ID: 9361155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodulosis during methotrexate therapy for rheumatoid arthritis.
    Das SK; Kumar A
    J Assoc Physicians India; 1995 Sep; 43(9):651. PubMed ID: 8773077
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results.
    Lau AN; Thorne JC; Movahedi M; Rampakakis E; Cesta A; Li X; Couto S; Sampalis J; Bombardier C;
    J Rheumatol; 2019 Aug; 46(8):874-886. PubMed ID: 30988121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the therapeutics of methotrexate in rheumatoid arthritis.
    Murphy G; Coughlan R; Devlin J; FitzGerald O; McCarthy G
    Ir Med J; 2009 Jun; 102(6):170-2. PubMed ID: 19722351
    [No Abstract]   [Full Text] [Related]  

  • 6. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
    Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs.
    Charles-Schoeman C; Burmester G; Nash P; Zerbini CA; Soma K; Kwok K; Hendrikx T; Bananis E; Fleischmann R
    Ann Rheum Dis; 2016 Jul; 75(7):1293-301. PubMed ID: 26275429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
    Mroczkowski PJ; Weinblatt ME; Kremer JM
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S66-8. PubMed ID: 10589360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated nodulosis during methotrexate therapy for refractory rheumatoid arthritis. A case report.
    Filosa G; Salaffi F; Bugatti L
    Adv Exp Med Biol; 1999; 455():521-4. PubMed ID: 10599392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment of rheumatoid arthritis with cyclosporine and methotrexate.
    Stein CM; Pincus T
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S47-52. PubMed ID: 10589357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O; Gibofsky A
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity.
    Landewé RB; van den Borne BE; Breedveld FC; Dijkmans BA
    Lancet; 2000 May; 355(9215):1616-7. PubMed ID: 10821370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angio-neurotic oedema associated with methotrexate treatment in rheumatoid arthritis.
    Freeman AM; Dasgupta B
    Rheumatology (Oxford); 1999 Sep; 38(9):908. PubMed ID: 10515658
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of rheumatoid arthritis].
    Bolten WW
    MMW Fortschr Med; 2008 Aug; 150(32-35):50-3; quiz 54. PubMed ID: 19006884
    [No Abstract]   [Full Text] [Related]  

  • 16. [Small molecules treatment in rheumatoid arthritis].
    Verdon A; Lauper K
    Rev Med Suisse; 2020 Mar; 16(685):477-480. PubMed ID: 32167248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern therapy of rheumatoid arthritis. Joint destruction can be delayed].
    Neumaier J
    MMW Fortschr Med; 2008 Apr; 150(14):14. PubMed ID: 18488571
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serious adverse effects of methotrexate therapy in patients with rheumatic arthritis].
    Purokivi M; Myllykangas-Luosujärvi R; Jantunen E
    Duodecim; 1998; 114(21):2187-90. PubMed ID: 11757107
    [No Abstract]   [Full Text] [Related]  

  • 19. Summaries for patients. Adding low-dose prednisone to methotrexate therapy for early rheumatoid arthritis.
    Ann Intern Med; 2012 Mar; 156(5):I18. PubMed ID: 22393145
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination therapy with cyclosporin in rheumatoid arthritis.
    Yocum DE
    Drugs; 1995; 50 Suppl 1():37-40. PubMed ID: 8714797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.